Facebook Twitter Instagram YouTube Linkedin Contact

Choroideremia Research

September 21, 2018

Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.

Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia

 

In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.

If you have a question related to choroideremia, please contact us at 214-363-3911.

 

❮ News Articles
Share on: Facebook Twitter Linkedin
Choroideremia Research

Related Articles

The Rosewood Foundation And Retina Foundation Of The Southwest Partner Up Again For “Keeping An Eye On Innovation” Series Phase III Treatment Trial for Stargardt Disease Enrolls First Patient Recently@Retina Newsletter September 2023 Discovering New Therapies for AMD New Technology Gives ‘Second Sight’ to the Blind
Mailicon
Get the Latest Updates

Sign up to receive emails from Retina Foundation that will keep you up-to-date on our research and events.

  • This field is for validation purposes and should be left unchanged.
Contact Us

Contact Us

  • This field is for validation purposes and should be left unchanged.
x

Please check all that apply:

How did you learn about the
Retina Foundation?

  • This field is for validation purposes and should be left unchanged.
  • Please check all that apply:
Contact Us

Request an Appointment

Please complete this form if you are interested in speaking to a member of our team about your AMD.

all fields required

DOWNLOAD Printable Form